| 000 | 01214 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517195815.0 | ||
| 264 | 0 | _c20190506 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a2169-141X | ||
| 024 | 7 |
_a10.1080/21691401.2018.1430583 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYoosefian, Mehdi | |
| 245 | 0 | 0 |
_aNanocarrier for levodopa Parkinson therapeutic drug; comprehensive benserazide analysis. _h[electronic resource] |
| 260 |
_bArtificial cells, nanomedicine, and biotechnology _c2018 |
||
| 300 |
_a434-446 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdsorption |
| 650 | 0 | 4 |
_aBenserazide _xchemistry |
| 650 | 0 | 4 | _aElectrons |
| 650 | 0 | 4 | _aHydrogen Bonding |
| 650 | 0 | 4 |
_aLevodopa _xchemistry |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 |
_aNanotubes, Carbon _xchemistry |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aQuantum Theory |
| 700 | 1 | _aRahmanifar, Elham | |
| 700 | 1 | _aEtminan, Nazanin | |
| 773 | 0 |
_tArtificial cells, nanomedicine, and biotechnology _gvol. 46 _gno. sup1 _gp. 434-446 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/21691401.2018.1430583 _zAvailable from publisher's website |
| 999 |
_c28022369 _d28022369 |
||